Chris Abell | |
---|---|
Chris Abell at the Royal Society admissions day in London, July 2016
|
|
Born | Christopher Abell November 11, 1957 |
Nationality | British |
Fields | Biological chemistry |
Institutions |
University of Cambridge Brown University |
Alma mater | University of Cambridge (BA, MA, PhD) |
Thesis | Polyketide biosynthesis (1982) |
Doctoral advisor | |
Doctoral students | Shankar Balasubramanian |
Known for | Astex, biosynthesis as targets for the rational design of antimicrobials; fragment-based approaches to enzyme inhibition; and biological nanotechnology |
Notable awards | |
Website www |
Christopher Abell FRS FRSCFMedSci (born 11 November 1957) is a British biological chemist. As of 2016, he is Professor of Biological Chemistry at the Department of Chemistry of the University of Cambridge and Todd-Hamied Fellow of Christ's College, Cambridge. On his 2016 election to the Royal Society, the society described his research as having "changed the face of drug discovery."
Abell was educated at St John's College, Cambridge, gaining an Bachelor of Arts degree in Natural Sciences in 1979 followed by PhD on the topic of polyketide biosynthesis for research supervised by in 1982.
Abell held a research fellowship in the laboratory of David E. Cane at Brown University, Providence, USA, studying terpene biosynthesis (1982–83). In 1984, Abell joined the Department of Chemistry of the University of Cambridge, successively holding the positions of demonstrator, lecturer and reader in chemical biology, and becoming Professor in Biological Chemistry in 2002. He has held visiting professorships at the Australian National University in Canberra, University of Santiago de Compostela, University of Canterbury, Christchurch, and the Université Paul Sabatier, Toulouse. He has been a fellow of Christ's College since 1986; and is the college's Todd-Hamied Fellow. In 2013 he was appointed the first Director of Postdoctoral Affairs at the University of Cambridge, and in 2016 was appointed Pro-Vice-Chancellor for Research.